Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

AMERICAN CONTRACT SYSTEMS, INC.

US

Last updated May 23, 2026

What AMERICAN CONTRACT SYSTEMS, INC. makes

American Contract Systems, Inc. manufactures single-use, non-medicated general surgical procedure kits designed for various surgical applications. These kits are intended for one-time use in operating room settings and include essential tools and instruments required for specific surgical procedures.

The company’s products are regulated under FDA classification as either Class I or Class II devices, with some falling under the non-classifiable (N) category. These devices are listed in the FDA’s Unique Device Identifier (UDI) database, ensuring traceability and compliance with U.S. regulatory requirements.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
010334675

Catalogue (21894)

Page 24 of 438
DeviceModel / ReferenceRegistriesClassStatus
Acs GUKN13E
FDA UDI
Class IActive
Acs EVAR41D
FDA UDI
Class IActive
Acs JEIR37C
FDA UDI
Class IIActive
Acs SPLP59L
FDA UDI
Class IIActive
Acs LLTJ52D
FDA UDI
Class IIActive
Acs LASH03X
FDA UDI
Class IActive
Acs CXBT11D
FDA UDI
Class IActive
Acs SFBA03G
FDA UDI
Class IIActive
Acs IHHD98M
FDA UDI
Class IIActive
Acs TPSP14B
FDA UDI
Class IActive
Acs CETH57D
FDA UDI
Class IIActive
Acs GIBB05F
FDA UDI
Class IIActive
Acs SHEN44E
FDA UDI
Class IIActive
Acs ISPM02F
FDA UDI
Class IIActive
Acs TOFP52D
FDA UDI
Class IIActive
Acs BHMY98E
FDA UDI
Class IIActive
Acs ESSP84B
FDA UDI
Class IIActive
Acs UICN40AD
FDA UDI
Class IIActive
Acs LMLP08V
FDA UDI
Class IIActive
Acs UICL44M
FDA UDI
Class IIActive
Acs MMLM03N
FDA UDI
Class IIActive
Acs BHSP82E
FDA UDI
Class IIActive
Acs FHPE19E
FDA UDI
Class IIActive
Acs UNPI38B
FDA UDI
Class IIActive
Acs CITJ02C
FDA UDI
Class IIActive
Acs PWTK04X
FDA UDI
Class IActive
Acs AMSC01A
FDA UDI
Class IIActive
Acs BPPU55A
FDA UDI
Class IIActive
Acs FHVD34N
FDA UDI
Class IIActive
Acs OSDV38D
FDA UDI
Class IIActive
Acs UHBA77K
FDA UDI
Class IIActive
Acs EGTH09A
FDA UDI
Class IIActive
Acs MMEN11D
FDA UDI
Class IActive
Acs HEOR93AI
FDA UDI
Class IIActive
Acs LMCL36G
FDA UDI
Class IIActive
Acs SJVO56D
FDA UDI
Class IIActive
Acs WEHD16B
FDA UDI
Class IActive
Acs SHCR60K
FDA UDI
Class IActive
Acs MHCV10AE
FDA UDI
Class IIActive
Acs IHOH21BN
FDA UDI
Class IIActive
Acs UTSL72V
FDA UDI
Class IIActive
Acs AHCS26W
FDA UDI
Class IIActive
Acs ICLC46E
FDA UDI
Class IIActive
Acs ANEX45AE
FDA UDI
Class IIActive
Acs FHVH35W
FDA UDI
Class IIActive
Acs LMLP08W
FDA UDI
Class IIActive
Acs GIAN68F
FDA UDI
Class IIActive
Acs IHMP89D
FDA UDI
Class IIActive
Acs TPAH21A
FDA UDI
Class IIActive
Acs LAPM00J
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

American Contract Systems, Inc. has 190 recall records spanning from December 28, 2016, to March 19, 2026, with statuses recorded as open, classified, or terminated. The reasons cited include concerns about incomplete sterilization, improper handling of components during sterilization processes, incorrect expiration dates, labeling errors, insufficient aeration time, and deviations from sterilization specifications. Some recalls involved third-party products or components, such as syringes from Medline Industries, and the use of FDA-banned substances in powdered surgical gloves.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 19, 2026Z-1981-2026—open, classified

Impacted kits contain syringes recalled by Medline Industries. Syringe rotating adaptor may unwind during use, which may result in a loose connection or full disconnection between the syringe and manifold. Potential risk for biohazard exposure, blood loss, infection, or air embolism.

Sep 4, 2025Z-0179-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0185-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0187-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0180-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0178-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0172-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0171-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0183-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0174-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0175-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0177-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0186-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0173-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0170-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0184-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0181-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0182-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0176-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Jul 14, 2025Z-2466-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2471-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2465-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2467-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2468-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2469-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2470-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2464-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2472-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Apr 21, 2025Z-1916-2025—open, classified

Test results for cast padding component included in procedure trays shows Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals exceeded residual limits, which may lead to a possible loss or lack of functionality that may lead to a delay or prolonged treatment/procedure/therapy.

Feb 6, 2025Z-1332-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1333-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1349-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1345-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1359-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1356-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1339-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1348-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1358-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1361-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1346-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1331-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1350-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1355-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1347-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1353-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1362-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1354-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1341-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1338-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1352-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1342-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1334-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1357-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1360-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1340-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1335-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1336-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1344-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1337-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1343-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1351-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 4, 2025Z-1406-2025—open, classified

During an internal investigation, ACS was unable to confirm that the CODMAN component achieved the required Sterility Assurance Level and therefore is not suitable for sterilization according to ACS procedures.

Jan 31, 2025Z-1425-2025—open, classified

Sterility assurance with procedure trays

Jan 31, 2025Z-1426-2025—open, classified

Sterility assurance with procedure trays

Jan 31, 2025Z-1424-2025—open, classified

Sterility assurance with procedure trays

Aug 7, 2024Z-3230-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3238-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3239-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3227-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3241-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3233-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3242-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3226-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3231-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3229-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3237-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3244-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3232-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3228-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3235-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3240-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3236-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3243-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3234-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

May 15, 2024Z-2274-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2277-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2304-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2283-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2310-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2290-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2284-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2275-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2301-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2299-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2280-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2281-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2307-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2306-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2303-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2308-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.